Evidence map›Paper›PMID 29389543›Full record

ReviewJournal of food and drug analysis2018

Studies on prevention of obesity, metabolic syndrome, diabetes, cardiovascular diseases and cancer by tea.

Chung Shu Yang, Hong Wang, Zachary Paul Sheridan

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of food and drug analysis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
8.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 131 citations in OpenAlex.

  1. Effect of Vitamin DNutrients · 2019
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chung Shu YangDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854-8020, USA.
Hong WangDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854-8020, USA.
Zachary Paul SheridanDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854-8020, USA.
Rutgers, The State University of New Jersey · US

Funding

Prevention of Colon Cancer by Epigallocatechin Gallate and AtorvastatinR01CA120915 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI YANG, CHUNG S. · 2007 to 2011
$1.8M
Mechanistic Studies on Lung Cancer Prevention by Tea PolyphenolsR01CA122474 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI YANG, CHUNG S. · 2008 to 2012
$1.6M
Inhibition of Lung Carcinogenesis by Tea Polyphenols and AtorvastatinR01CA133021 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI YANG, CHUNG S. · 2008 to 2012
$1.6M
NCI NIH HHS R01 CA120915NCI NIH HHS R01 CA122474NCI NIH HHS R01 CA133021
6 · The paper itself

Abstract

Tea, a popular beverage made from leaves of the plant Camellia sinensis, has been studied extensively in recent decades for its beneficial health effects in the prevention of obesity, metabolic syndrome, diabetes, cancer, and other diseases. Whereas these beneficial effects have been convincingly demonstrated in most laboratory studies, results from human studies have not been consistent. Some studies demonstrated that weight reduction, alleviation of metabolic syndrome and risk reduction in diabetes were only observed in individuals who consume 3-4 cups of tea (600-900 mg tea catechins) or more daily. This chapter reviews some of these studies, the possible mechanisms of actions of tea constituents, and the challenges in extrapolating laboratory studies to human situations.

Indexed as

TeaAnimalsBiological AvailabilityBiomarkersBody WeightCardiovascular DiseasesDiabetes MellitusDisease Models, AnimalHumansMetabolic SyndromeNeoplasmsObesityPhytochemicalsPolyphenolsProtective AgentsBiomarkersPhytochemicalsPolyphenolsProtective AgentsTeaCancerDiabetesMetabolic syndromeObesityPolyphenols

Identifiers

PMID29389543
PMCPMC9332647
OpenAlexW2775559830

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.